Shuang Guo | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Citation Awards

Shuang Guo | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr Shuang Guo, Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital: Beijing Tsinghua Changgung Hospital, China

Dr. Shuang Guo is a dedicated postdoctoral researcher at Beijing Tsinghua Changgung Hospital, affiliated with the School of Clinical Medicine at Tsinghua University. With a Ph.D. in Clinical Medicine from the prestigious Huazhong University of Science and Technology, Dr. Guo has contributed significantly to the field of cardiovascular and genetic diseases. Her multidisciplinary research approach bridges clinical practice with cutting-edge molecular science, emphasizing hereditary arrhythmias, hypertension, and vascular disorders. Dr. Guo has published influential articles in international journals and is actively involved in innovation, holding several patents related to vascular health and gastrointestinal treatments. As a passionate investigator and co-developer of novel diagnostic and therapeutic strategies, she consistently pushes the boundaries of translational medicine. Dr. Guo’s dedication to scientific excellence and patient-centered research continues to enhance understanding and treatment of complex hereditary and vascular diseases in China and beyond.

Publication Profile

orcid

Education 

Dr. Shuang Guo earned her Ph.D. in Clinical Medicine from the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, one of China’s top institutions in medical education and biomedical research. During her doctoral training, she cultivated a solid foundation in cardiovascular pathology, molecular diagnostics, and translational medicine. Her academic journey was marked by hands-on clinical exposure combined with deep exploration of hereditary diseases, enabling her to integrate lab-based discoveries with bedside care. The program offered her robust mentorship and multidisciplinary collaboration opportunities that enhanced her clinical insight and research acumen. This rigorous educational experience provided the basis for her continued research excellence and led directly to her postdoctoral appointment at Tsinghua University. Her academic background also includes comprehensive training in medical genetics, vascular physiology, and clinical trial design, which continues to inform her postdoctoral investigations into novel treatments and personalized care for cardiovascular and hereditary disorders.

Experience

Currently serving as a postdoctoral researcher at Beijing Tsinghua Changgung Hospital, affiliated with the School of Clinical Medicine, Tsinghua University, Dr. Shuang Guo focuses on vascular biology, hereditary cardiovascular diseases, and precision medicine. Her postdoctoral work includes conducting high-impact research, co-authoring clinical trials, and filing patents on molecular therapies for gastrointestinal and vascular diseases. She collaborates with a multidisciplinary team of clinicians, biologists, and bioengineers to translate laboratory findings into therapeutic solutions. Before her postdoc, she gained extensive research experience at Huazhong University of Science and Technology, where she contributed to translational cardiovascular studies and clinical case analyses at Union Hospital. Dr. Guo is also actively engaged in manuscript writing, grant applications, and patent development, underscoring her commitment to innovation and collaboration. Her professional journey demonstrates a strong intersection of research excellence and clinical relevance, with a focus on improving diagnostic and therapeutic outcomes in genetically mediated and vascular-related conditions.

Awards and Honors

While specific named awards are not listed, Dr. Shuang Guo’s contributions to the medical and scientific community are demonstrated through her leadership as first author in multiple peer-reviewed journals, co-first authorship in a major JACC publication, and her involvement in five innovative patents related to gastrointestinal and vascular health. Her research has garnered recognition in respected publications such as Genes, Journal of Vascular Surgery, and JACC: Basic to Translational Science, reflecting high scholarly merit. These achievements speak to her excellence in both foundational research and applied clinical studies. Dr. Guo’s role in inventing novel uses of inulin, identifying mutation genes associated with hypercholesterolemia, and contributing to the development of therapeutic applications for short-chain fatty acids highlights her contribution to innovation. Her growing reputation in cardiovascular and hereditary disease research underscores her role as a rising scientific leader. Future recognition is likely as her contributions continue to impact global healthcare.

Research Focus

Dr. Shuang Guo’s research is rooted in clinical and molecular investigation of hereditary cardiovascular and gastrointestinal diseases. Her primary focus areas include genetic arrhythmias, monogenic hypertension, vascular inflammation, and abdominal aortic aneurysms. She is particularly interested in translational research—bridging the gap between genetic findings and clinical applications. Her work explores the therapeutic potential of dietary fibers like inulin and microbiota-derived short-chain fatty acids in modulating immune responses and vascular health. Dr. Guo’s ongoing studies involve identifying novel genetic mutations linked to hypercholesterolemia and other inherited conditions. She applies molecular biology, clinical diagnostics, and bioinformatics to uncover mechanisms underlying disease progression. Her research also emphasizes the role of immune modulation in disease treatment, especially via regulatory T-cell activity in vascular disorders. Through multidisciplinary collaboration, she aims to develop minimally invasive strategies and precision-based therapies to improve patient care, focusing on personalized medicine in complex, genetically-influenced disease models.

Publication Top Notes

  • 📘 Pathogenesis and Clinical Characteristics of Hereditary Arrhythmia Diseases – Genes, 2024.

  • 📗 Selective Minimally Invasive Strategy for Acute Superior Mesenteric Artery Obstruction – Journal of Vascular Surgery, 2025.

  • 📙 Propionate Alleviates Abdominal Aortic Aneurysm by Modulating Colonic Regulatory T-Cell Expansion and Recirculation – JACC: Basic to Translational Science, 2022.

  • 📕 Research Advances in Monogenic Inherited Hypertension – 中国医学前沿杂志(电子版), 2024

HUMA FATIMA | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

Published on by Citation Awards

HUMA FATIMA | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

Ms HUMA FATIMA, Indian Institute of Technology Delhi, India

Dr. [Your Name] recently submitted a Ph.D. thesis titled “Studies on β-lactamase from Bacillus tropicus EMB20 for alleviation of antibiotic pollution and antimicrobial resistance” at IIT Delhi. Their research focuses on enzyme biocatalysis, molecular biology, and nanobiotechnology, specifically exploring β-lactamase expression, purification, and immobilization for antibiotic degradation. They pioneered enzyme immobilization techniques to enhance stability and reusability and contributed to whole-genome sequencing of Bacillus tropicus EMB20. Additionally, they synthesized meropenem nanoflowers with potent antibacterial and antibiofilm activity. Their interdisciplinary expertise spans protein biochemistry, synthetic microbiology, antimicrobial assays, and nanomaterial characterization. Passionate about sustainable environmental management, they aim to develop enzyme-based solutions for tackling antibiotic pollution and antimicrobial resistance. Recognized with prestigious fellowships and travel awards, they have published impactful research in high-impact journals. They aspire to leverage their expertise in a postdoctoral role, contributing to cutting-edge advancements in biotechnology and environmental remediation.

Publication Profile

scopus

Education

Dr.HUMA FATIMA  holds a Doctor of Philosophy (Ph.D.) in Chemistry from IIT Delhi (2019-2024), where their research focused on β-lactamase from Bacillus tropicus EMB20 for alleviating antibiotic pollution and antimicrobial resistance. Under the guidance of Prof. Sunil Kumar Khare and Prof. Preeti Srivastava, they worked extensively on enzyme expression, purification, immobilization, and nanobiotechnology applications. Prior to this, they completed a Master of Science (M.Sc.) in Biosciences from Jamia Millia Islamia, New Delhi (2015-2017), with an outstanding CGPA of 9.0/10. Under the supervision of Prof. Luqman Ahmad Khan, they explored antimicrobial resistance mechanisms and enzyme biocatalysis, earning a Gold Medal for academic excellence. They also hold a Bachelor of Science (B.Sc.) in Biotechnology from the same university (2012-2015), where they achieved a remarkable CGPA of 9.8/10 and was honored with another Gold Medal. Their academic journey reflects a strong foundation in biotechnology, microbiology, and environmental bioremediation.

Experience

Dr. HUMA FATIMA has extensive research experience in enzyme biocatalysis and nanobiotechnology. As a Ph.D. Research Scholar at IIT Delhi (2019-2024), they focused on β-lactamase enzymes for antibiotic degradation, developing innovative immobilization techniques to enhance stability and reusability. Their work also included nanobiotechnology approaches, such as synthesizing nanoflowers with antibacterial properties, and contributing to the whole-genome sequencing of Bacillus tropicus EMB20. During their M.Sc. at Jamia Millia Islamia (2015-2017), they investigated antimicrobial resistance mechanisms under Prof. Luqman Ahmad Khan. Additionally, as a Research Assistant in a biotechnology lab (2017-2019), they gained expertise in molecular biology, protein purification, and enzyme kinetics. Their academic excellence has been recognized through multiple awards, including the RETA Grant (2024) and RSTA Grant (2023) from IIT Delhi, the prestigious DST INSPIRE Fellowship (2019), and qualifications in CSIR-NET (2017) and GATE (2018). They also earned Gold Medals for their M.Sc. (2017) and B.Sc. (2015) degrees at Jamia Millia Islamia.

Awards & Honors

Dr. HUMA FATIMA  has been recognized with several prestigious awards and honors for academic excellence and research contributions. They received the Research Excellence Travel Award (RETA) from IIT Delhi in 2024 and the Research Scholar Travel Award (RSTA) in 2023, enabling them to present their research at international conferences. In 2019, they were awarded the highly competitive DST INSPIRE Fellowship (IF19004) by the Government of India, supporting their doctoral studies. Their academic achievements include qualifying the CSIR-NET (Lectureship) in 2017 and GATE in Life Sciences in 2018, demonstrating their strong grasp of biosciences. Their exceptional performance during their postgraduate and undergraduate studies earned them Gold Medals in M.Sc. Biosciences (2017) and B.Sc. Biotechnology (2015) from Jamia Millia Islamia, New Delhi. These accolades highlight their dedication to research, innovation, and excellence in the fields of biotechnology, molecular biology, and environmental sustainability.

Research Focus

Dr. HUMA FATIMA  specializes in enzyme biocatalysis, molecular biology, and nanobiotechnology for addressing environmental and health challenges. Their primary research revolves around β-lactamase enzymes for antibiotic degradation, combating antimicrobial resistance, and reducing pharmaceutical pollution. They have developed advanced enzyme immobilization techniques to enhance enzyme reusability and stability. Their work extends to the whole-genome sequencing of Bacillus tropicus EMB20, providing insights into its biotechnological potential. Additionally, they have explored nanomaterials for biomedical applications, including the synthesis of meropenem nanoflowers with potent antibacterial and antibiofilm properties. Their interdisciplinary expertise includes protein purification, synthetic microbiology, antimicrobial assays, and nanomaterial characterization. Passionate about sustainable solutions, they aim to apply their research to environmental bioremediation, public health, and industrial biotechnology.

Publication Top Notes

1️⃣ Applicability of β-lactamase entrapped agarose discs for removal of doripenem antibiotic: reusability and scale-up studies – Environmental Science: Water Research & Technology (Accepted)
2️⃣ Efficient remediation of meropenem using Bacillus tropicus EMB20 β-lactamase immobilized on magnetic nanoparticles – J Environ Manage, 329, 117054 (2023)
3️⃣ Insights from the genome sequence of Bacillus tropicus EMB20, an efficient β-lactamase-producing bacterium – 3 Biotech, 12(12), 330 (2022)
4️⃣ Meropenem incorporated Nanoflowers as Nano Antibiotics: A Promising Strategy for Combating Antimicrobial Resistance and Biofilm-Associated Infections – Inorg. Chem. Commun. (Under Review)
5️⃣ Cloning and expression of β-lactamase gene from B. tropicus EMB20 with non-classical inclusion bodies – Submitted to Int. J. Biological Macromolecules